Charlie Stross on Nostr: The NHS is currently facing supply issues with glucagon-like peptide receptor ...

The NHS is currently facing supply issues with glucagon-like peptide receptor agonists (GLP-1 RAs), a range of drugs used for managing blood glucose levels in people with type 2 diabetes.

The global shortage in supply is partly due to a surge in off label prescriptions of the drug semaglutide being issued for weight loss which is outstripping supply.

https://www.diabetes.org.uk/about_us/news/our-response-serious-supply-issues-drugs-people-living-type-2-diabetes